Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap
Top Cited Papers
- 25 May 2010
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 67 (6), 699-714
- https://doi.org/10.1002/ana.22053
Abstract
Human immunodeficiency virus (HIV)‐associated neurocognitive disorders (HANDs) remain among the most common disorders in people infected with HIV, even in an era when potent antiretroviral therapy is widely deployed. This review discusses the clinical features of HANDs and the implications for more effective treatment. With the improved survival of individuals treated with antiretrovirals, comorbid conditions are increasingly salient, including particularly coinfection with hepatitis C and the effects of aging. This review attempts to answer why there appears to be a therapeutic gap between the salutary effects of antiretroviral regimens and normalization of neurological function. A second gap is found in the understanding of the pathophysiology of HANDs. This review addresses this and discusses the animal models that have helped to elucidate these mechanisms. Although triggered by productive HIV infection of brain macrophages, aberrant and sustained immune activation appears to play a major role in inducing HANDs, and may explain the often incomplete neurological response to highly active antiretroviral therapy. Novel therapies aimed at persistent central nervous system inflammation will be needed to close this gap. ANN NEUROL 2010;67:699–714Keywords
This publication has 168 references indexed in Scilit:
- Biomarkers of neurological status in HIV infection: A 3‐year studyProteomics – Clinical Applications, 2010
- Synaptic Proteins Linked to HIV-1 Infection and Immunoproteasome Induction: Proteomic Analysis of Human SynaptosomesJournal of Neuroimmune Pharmacology, 2009
- Evidence for ongoing brain injury in human immunodeficiency virus–positive patients treated with antiretroviral therapyJournal of NeuroVirology, 2009
- Serum matrix metalloproteinase levels correlate with brain injury in human immunodeficiency virus infectionJournal of NeuroVirology, 2009
- Recent progress in antiretrovirals – lessons from resistanceDrug Discovery Today, 2008
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous SystemArchives of Neurology, 2008
- Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapyJournal of NeuroVirology, 2008
- Abnormal Striatal Dopaminergic Synapses in National NeuroAIDS Tissue Consortium Subjects with HIV EncephalitisJournal of Neuroimmune Pharmacology, 2006
- AIDS dementia complex and HIV‐1 brain infection: Clinical‐virological correlationsAnnals of Neurology, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995